DCTH

DELCATH SYSTEMS, INC.

Nasdaq · Surgical & Medical Instruments & Apparatus · Inc. DE · CIK 0000872912
$10.94 +2.53% $403.6M
Insider Buying Cluster (2 insiders)High Impact Filing (8/10)3 New Institutional Positions
Vol
Market Cap$403.6M
Cap SizeSmall Cap
Inst. Holders7 funds
Inst. Value$25.3M
Inst. Activity3 buys / 2 sells
Insider Activity2B / 0S
Insider Net $$150.3K
SEC Reports6
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0000872912·Prev Close $10.67

Recent Activity

Jun 8, 2026 short_volume
Short Volume: DCTH — 66.8% short (0.4M / 0.7M)
Short: 441,075 | Exempt: 989 | TRF Vol: 660,212 | Short Ratio: 66.8% | Off-exchange volume (dark poo
May 14, 2026 SEC
Delcath Systems filed an 8-K reporting that stockholders approved an amendment to the 2020 Omnibus Equity Incentive Plan
8-K — Impact 3/10
May 13, 2026 Insider
CZEREPAK ELIZABETH sold 22,500 shares
Director @ $0.00 ($0.00)
May 13, 2026 Insider
SALAMON STEVEN A J sold 22,500 shares
Director @ $0.00 ($0.00)
May 13, 2026 Insider
Aharon Gil sold 22,500 shares
Director @ $0.00 ($0.00)
May 7, 2026 SEC
Delcath Systems reported Q1 2026 revenue of $25.0M (+26% YoY), beating the $23.4M consensus, but posted a GAAP net loss
8-K — Impact 5/10
Apr 2, 2026 SEC
Delcath Systems, Inc. filed definitive additional proxy materials (DEFA14A) related to a shareholder vote. The filing ap
DEFA14A — Impact 3/10
Inst.
RENAISSANCE TECHNOLOGIES LLC — ADD
361,599 shares ($3.7M)

Price Targets

Historical data — last covering-analyst action Feb 2026. No current recommendation available.
$21.29 (Feb 2026)
Current $11.69 Low $18.00 Median $20.00 High $29.76 6 analysts
$18.00 $29.76

Analyst Ratings

Historical distribution92% buy · 13 analysts · last covering-analyst action Feb 2026
4Strong Buy
8Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Feb 26, 2026 BTIG MAINTAIN Buy → Buy
Jan 9, 2026 HC Wainwright & Co. REITERATE Buy → Buy

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.10 ▲ +18.0% $-0.16 — $-0.05 -250% YoY 4
Next Q $-0.24 ▼ -2.4% $-0.29 — $-0.17 -1288% YoY 4
Current FY $-0.63 ▲ +0.9% $-0.91 — $-0.44 -893% YoY 5
Next FY $-0.38 ▼ -95.6% $-0.66 — $-0.15 40% YoY 3

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$16.9M
RENAISSANCE TECHNOLOGIES LLC$3.7MADD
MORGAN STANLEY$3.1MTRIM
CHARLES SCHWAB INVESTMENT MANAGEMENT$867.4KDOUBLED
BANK OF AMERICA CORP$378.5KTRIM

Recent Insider Trades

DateInsiderTypeValue
May 13, 2026CZEREPAK ELIZABETHA$0.00
May 13, 2026SALAMON STEVENA$0.00
May 13, 2026Aharon GilA$0.00
May 13, 2026Martell BridgetA$0.00
May 13, 2026Sylvester JohnA$0.00
7 institutional holders with $25.3M total value (2,506,170 shares) as of 2025-Q4. Top holders: VANGUARD, RENAISSANCE, MORGAN. Net buying activity: 3 institutions added/increased vs 2 reduced.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC1,672,357$16.9M66.7%
2RENAISSANCE TECHNOLOGIES LLC361,599$3.7M14.4%ADD +41.1%
3MORGAN STANLEY308,550$3.1M12.3%TRIM -44.7%
4CHARLES SCHWAB INVESTMENT MANAGEMENT INC85,882$867.4K3.4%DOUBLED +578.8%
5BANK OF AMERICA CORP /DE/37,480$378.5K1.5%TRIM -66.1%
6WELLS FARGO & COMPANY/MN32,820$331.5K1.3%ADD +77.0%
7FMR LLC7,482$75.6K0.3%DOUBLED +2755.7%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
RENAISSANCE TECHNOLOGIES LLCADD256,200361,599+41.1%$3.7M2025-Q4
BANK OF AMERICA CORP /DE/TRIM110,64137,480-66.1%$378.5K2025-Q4
WELLS FARGO & COMPANY/MNADD18,54132,820+77.0%$331.5K2025-Q4
FMR LLCDOUBLED2627,482+2755.7%$75.6K2025-Q4
TWO SIGMA INVESTMENTS, LPEXIT18,0060-100.0%$0.002025-Q4
RENAISSANCE TECHNOLOGIES LLCADD178,000256,200+43.9%$2.8M2025-Q3
MORGAN STANLEYTRIM457,440253,015-44.7%$2.7M2025-Q3
UBS Group AGDOUBLED56,891114,831+101.8%$1.2M2025-Q3
TWO SIGMA INVESTMENTS, LPNEW18,006$193.6K2025-Q3
FMR LLCTRIM471262-44.4%$2.8K2025-Q3
MORGAN STANLEYADD343,131457,440+33.3%$6.2M2025-Q2
RENAISSANCE TECHNOLOGIES LLCDOUBLED71,300178,000+149.6%$2.4M2025-Q2
CHARLES SCHWAB INVESTMENT MANAGEMENT INCDOUBLED13,09188,858+578.8%$1.2M2025-Q2
UBS Group AGADD32,86156,891+73.1%$773.7K2025-Q2
WELLS FARGO & COMPANY/MNDOUBLED5,16415,821+206.4%$215.2K2025-Q2
MORGAN STANLEYADD172,022343,131+99.5%$4.4M2025-Q1
CITADEL ADVISORS LLCTRIM359,701194,552-45.9%$2.5M2025-Q1
RENAISSANCE TECHNOLOGIES LLCTRIM138,24271,300-48.4%$907.6K2025-Q1
UBS Group AGADD20,65732,861+59.1%$418.3K2025-Q1
WELLS FARGO & COMPANY/MNDOUBLED1,5035,164+243.6%$65.7K2025-Q1
CITADEL ADVISORS LLCADD233,761359,701+53.9%$4.3M2024-Q4
MORGAN STANLEYADD106,476172,022+61.6%$2.1M2024-Q4
RENAISSANCE TECHNOLOGIES LLCTRIM311,800138,242-55.7%$1.7M2024-Q4
UBS Group AGDOUBLED1,52120,657+1258.1%$248.7K2024-Q4
CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW12,977$156.2K2024-Q4
7 unique insiders with 2 transactions. Net insider value: $150.3K ($150.3K bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
May 13, 2026CZEREPAK ELIZABETHDirectorA22,500$0.00$0.00
May 13, 2026SALAMON STEVEN A JDirectorA22,500$0.00$0.00
May 13, 2026Aharon GilDirectorA22,500$0.00$0.00
May 13, 2026Martell Bridget ADirectorA22,500$0.00$0.00
May 13, 2026Sylvester John RichardDirectorA22,500$0.00$0.00
Mar 6, 2026Pennell SandraChief Financial OfficerBUY5,533$9.04$50.0K
Mar 2, 2026MICHEL GERARD JCHIEF EXECUTIVE OFFICERBUY11,200$8.96$100.3K

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Feb 2026): 92% buy across 13 analysts — 4 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Analyst Price Targets

Historical data — last covering-analyst action Feb 2026. No current recommendation available.
$21.29 mean target (Feb 2026)
$18.00 Low $29.76 High
MetricValue
Current Price$11.69
Target Low$18.00
Target Mean$21.29
Target Median$20.00
Target High$29.76
# Analysts6
Recommendation— (no recent coverage)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$-0.10 $-0.16 $-0.05 -250.0% +18.0% 0↑ 3↓ $0.0B 9.4% 4
Next Q
2026-09-30
$-0.24 $-0.29 $-0.17 -1287.5% -2.4% 0↑ 3↓ $0.0B 4
Current FY
2026-12-31
$-0.63 $-0.91 $-0.44 -892.5% +0.9% 0↑ 5↓ $0.1B 21.4% 5
Next FY
2027-12-31
$-0.38 $-0.66 $-0.15 39.5% -95.6% 0↑ 4↓ $0.1B 29.5% 3

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.105
7d ago$-0.114+0.009
30d ago$-0.128+0.023
60d ago$-0.128+0.023
90d ago$0.057-0.162
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Feb 26, 2026 BTIG MAINTAIN Buy Buy
Jan 9, 2026 HC Wainwright & Co. REITERATE Buy Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20264810092%
May 1, 20264810092%
Apr 1, 20264810092%
Mar 1, 20264810092%
Feb 1, 20264810092%
Jan 1, 20264810092%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Jun 8, 2026
short_volume
Short Volume: DCTH — 66.8% short (0.4M / 0.7M)
Short: 441,075 | Exempt: 989 | TRF Vol: 660,212 | Short Ratio: 66.8% | Off-exchange volume (dark pool + OTC)
May 7, 2026
earnings_calendar
DCTH Q1 2026 Earnings Scheduled — 2026-05-07
Feb 26, 2026
earnings_calendar
DCTH Q4 2025 Earnings Before Market Open — 2026-02-26
Feb 23, 2026
short_interest
FTD: DCTH — 69,858 shares ($0.7M) failed to deliver
Settlement: 20260223, Price: $9.78, FTD Value: $683,211.24, DELCATH SYS INC